FDA Enforcement
Class II
Ongoing
PulseSpray Infusion System devices including: PULSE SPRAY 5F/135/20, UPN: H787125004045, REF: 12500404; Pulse Spray 3Fx135x20, UPN: H787125004155, REF: 12500415; and PULSE SPRAY 5F/45/10, UPN: H787125004235, REF: 12500423.
Recall: Z-1010-2024
·
Reported February 14, 2024
Enforcement
- Recall Number
- Z-1010-2024
- Event ID
- 93744
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Angiodynamics, Inc.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- February 14, 2024
- Initiation Date
- December 18, 2023
- Classification Date
- February 7, 2024
- Address
- 603 Queensbury Ave, Queensbury, NY, 12804-7619, United States
Description
PulseSpray Infusion System devices including: PULSE SPRAY 5F/135/20, UPN: H787125004045, REF: 12500404; Pulse Spray 3Fx135x20, UPN: H787125004155, REF: 12500415; and PULSE SPRAY 5F/45/10, UPN: H787125004235, REF: 12500423.
Reason
Rotating adaptor O-ring manufacturing defect impacting seal integrity which may lead to a leak during infusion of medication.
Code Info
UDI-DI: 15051684013109, REF: 12500404, Lot: 5795345; UDI-DI: 15051684013215, REF: 12500415, Lot: 5793480; UDI-DI: 15051684013291, REF: 12500423, Lot: 5795344.
Distribution
United States (MD, LA & UT), Austria, Canada and Spain.
Quantity
7 eaches